The Frontiers of Drug Carrier |
S. Nakagawa |
J. Pharm. Soc. Jpn., 127(5),779-779, 2007 |
|
Drug and Gene Delivery by “Bubble Liposomes” and Ultrasound |
K. Maruyama, R. Suzuki, T. Takizawa, N. Utoguchi, and Y. Negishi |
J. Pharm. Soc. Jpn., 127(5),781-787, 2007 |
|
Development of Intracellular Drug Delivery System Using Fusogenic Liposomes |
T. Yoshikawa, N. Okada, and S. Nakagawa |
J. Pharm. Soc. Jpn., 127(5),789-796, 2007 |
|
Bio-nanocapsules for In vivo Pinpoint Drug Delivery |
J. Jung, T. Kasuya, K. Tanizawa, and S. Kuroda |
J. Pharm. Soc. Jpn., 127(5),797-805, 2007 |
|
Application of Atelocollagen-mediated siRNA Delivery for RNAi Therapies |
K. Honma, F. Takeshita, and T. Ochiya |
J. Pharm. Soc. Jpn., 127(5),807-812, 2007 |
|
Design of Nanohydrogel-Incorporated Microcapsules for Appropriate Controlled-Release of Peptide Drugs |
H. Ichikawa and Y. Fukumori |
J. Pharm. Soc. Jpn., 127(5),813-823, 2007 |
|
Development of Functional Drug Carriers to Realize Advanced Medical Therapy |
Y. Tabata |
J. Pharm. Soc. Jpn., 127(5),825-837, 2007 |
|
Safety and Efficacy of Cell/Tissue Medical Products |
T. Yamaguchi and T. Tsuchiya |
J. Pharm. Soc. Jpn., 127(5),839-840, 2007 |
|
Endothelial Progenitor Cells for Vascular Medicine |
T. Asahara |
J. Pharm. Soc. Jpn., 127(5),841-845, 2007 |
|
Development of Cell/Tissue-Based Medical Products |
T. Tsuchiya |
J. Pharm. Soc. Jpn., 127(5),841-850, 2007 |
|
Safety Evaluation of Tissue Engineered Medical Devices Using Normal Human Mesenchymal Stem Cells |
R. Sawada, T. Ito, and T. Tsuchiya |
J. Pharm. Soc. Jpn., 127(5),851-856, 2007 |
|
Present Status and Perspective of Articular Cartilage Regeneration |
S. Wakitani |
J. Pharm. Soc. Jpn., 127(5),857-863, 2007 |
|
Research on the Marketing Status of Antimicrobial Products and the Use of Antimicrobial Agents Indicated on the Product Labels: From 1991 through 2005 |
H. Nakashima, N. Miyano, I. Matsunaga, N. Nakashima, and M. Kaniwa |
J. Pharm. Soc. Jpn., 127(5),865-888, 2007 |
|
The Extract of Gynostemma pentaphyllum Enhanced the Production of Antibodies and Cytokines in Mice |
W.-C. Huang, M.-L. Kuo, M.-L. Li, R.-C. Yang, C.-J. Liou, and J.-J. Shen |
J. Pharm. Soc. Jpn., 127(5),889-896, 2007 |
|
Pharmacokinetics of Antifungal Agent Micafungin in Critically Ill Patients Receiving Continuous Hemodialysis Filtration |
K. Hirata, T. Aoyama, Y. Matsumoto, F. Ogawa, H. Yamazaki, A. Kikuti, and Y. Yamamoto |
J. Pharm. Soc. Jpn., 127(5),897-901, 2007 |
|
Antibacterial Activity of Ciprofloxacin against Clinical Strains of Vibrio cholerae O139 recently Isolated from India |
Jun Okuda, Thandavarayan Ramamurthy, and Shinji Yamasaki |
J. Pharm. Soc. Jpn., 127(5),903-904, 2007 |
|
Analysis of Students, Achievement Rate and Contents of Assessment for Objective Structured Clinical Examination (OSCE) Attempted at the Faculty of Pharmaceutical Sciences, Showa University |
M. Kogo, N. Koyama, T. Negoro, K. Aoki, I. Saito, Y. Kobayashi, J. Mashimo, K. Sasaki, T. Tobe, T. Yamamoto, Y. Kiuchi, and H. Sato |
J. Pharm. Soc. Jpn., 127(5),905-917, 2007 |
|